WA HB1697

State Board of Health must reestablish the newborn screening panel by January 1, 2027, incorporating all conditions currently screened (32 rare congenital conditions) plus all conditions on the federal recommended uniform screening panel as of January 1, 2025

Within one calendar year of any new condition being added to the federal recommended uniform screening panel, the State Board of Health must determine whether to add it to Washington's panel after completing a feasibility review covering costs, federal funding availability, fee recommendations, and implementation timeline

Creates the newborn screening revenue account in the state treasury to collect all screening fees; funds may be used only for implementing and administering the screening program and do not require legislative appropriation

Maintains the existing $8.40 fee per infant to fund specialty clinics providing treatment services and organizations conducting community outreach, education, and adult support for sickle cell disease

Preserves the public's ability to petition for conditions to be added to the screening panel outside of the federal recommended uniform screening panel through a separate feasibility review process